2 min read
Press Releases
Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.
2 min read
AGC Biologics Completes PPQ Manufacturing with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab
![AGC Biologics Milan facilities.](https://www.agcbio.com/hubfs/MolMed%20Slide-1.png)
2 min read
AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program
1 min read
AGC Biologics Expands Development Capacities for pDNA Services at Heidelberg Site
2 min read
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
2 min read